Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
ThermoGenesis Holdings's peak revenue was $23.4M in 2011. The peak quarterly revenue was $5.4M in 2011(q4).
ThermoGenesis Holdings's revenue increased from $11.6m in 2004 to $9.4M currently. That's a -18.9% change in annual revenue.
| Fiscal year / year | ThermoGenesis Holdings revenue |
|---|---|
| 2009 | $19.8M |
| 2010 | $23.1M |
| 2011 | $23.4M |
| 2012 | $19.0M |
| 2013 | $18.0M |
| 2014 | $16.0M |
| 2015 | $16.0M |
| 2016 | $11.9M |
| 2017 | $14.5M |
| 2018 | $9.7M |
| 2019 | $13.0M |
| 2020 | $9.7M |
| 2021 | $9.3M |
| 2022 | $10.5M |
| 2023 | $9.4M |
How accurately did ThermoGenesis Holdings' revenue projections match actual performance?
ThermoGenesis Holdings saw the greatest revenue growth in 2007, when revenue increased by 39.04%.
ThermoGenesis Holdings had the lowest revenue growth in 2018, when revenue changed by -33.41%.
| Year | ThermoGenesis Holdings growth |
|---|---|
| 2009 | -10%↓ |
| 2010 | 17%↑ |
| 2011 | 1%↑ |
| 2012 | -19%↓ |
| 2013 | -6%↓ |
| 2014 | -11%↓ |
| 2015 | 0%↑ |
| 2016 | -26%↓ |
| 2017 | 22%↑ |
| 2018 | -33%↓ |
| 2019 | 35%↑ |
| 2020 | -25%↓ |
| 2021 | -5%↓ |
| 2022 | 13%↑ |
| 2023 | -10%↓ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2011 | - | - | - | $5.4M |
| 2012 | $4.9M | $4.8M | $4.9M | $4.5M |
| 2013 | $4.1M | $4.8M | $4.9M | $4.1M |
| 2014 | $3.6M | $4.5M | $4.0M | $3.8M |
| 2015 | $3.7M | $4.6M | $4.0M | $3.7M |
| 2016 | $2.8M | $3.3M | $3.8M | $3.0M |
| 2017 | $3.3M | $3.5M | $3.1M | - |
| 2018 | $1.9M | $2.0M | $3.1M | $2.7M |
| 2019 | $3.0M | $4.3M | $4.1M | $1.7M |
| 2020 | $3.2M | $2.2M | $2.4M | $1.9M |
| 2021 | $1.5M | $2.2M | $3.2M | $2.4M |
| 2022 | $2.7M | $3.0M | $2.1M | $2.7M |
| 2023 | $2.6M | $2.3M | $2.2M | $2.4M |
| 2024 | $2.7M | - | - | - |
Do you work at ThermoGenesis Holdings?
Is ThermoGenesis Holdings transparent about its revenue structure?
| CEO | Mr. Matthew T. Plavan |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 37 |
| Date Founded | 1987 |
| Headquarters | Rancho Cordova, California |
| Number of Locations | 1 |
| Revenue | $9.4M |
| Net Income | -$11,270,000 |
| Gross Proft | $1.9M (2023) |
| PE Ratio | -0.43 |
| Tax Rate | 0.3% |
| Market Capitalization | $7.8M |
| Total Assets | $19,386,000 |
| Ticker | THMO |
ThermoGenesis Holdings received early financing of $15.0M on 2015.
| Series | Round size | Date |
|---|---|---|
| Equity | $800K | 2019 |
| Options | $817K | 2018 |
| Equity | $15M | 2016 |
| Debt | $15M | 2015 |
ThermoGenesis Holdings's top competitor, SynGen, earned an annual revenue of $12.6B.
ThermoGenesis Holdings's smallest competitor is Liveyon with revenue of $1.9M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Cryo-Cell | $50,603 | $25.4M | 98 | - |
| Liveyon | $45,307 | $1.9M | 75 | - |
| SynGen | $78,108 | $12.6B | 28,704 | - |
| Molecular Devices | $85,783 | $150.0M | 631 | - |
| Bovie Medical | $78,194 | $44.5M | 200 | 4 |
| Cardima | $47,234 | - | 50 | - |
| AtriCure | $72,233 | $465.3M | 620 | 104 |
| Spiration | $50,165 | $11.0M | 79 | - |
| BARRX Medical | $45,247 | $6.3M | 50 | - |
| Spacelabs Healthcare | $96,851 | $1.5B | 1,043 | - |
Zippia gives an in-depth look into the details of ThermoGenesis Holdings, including salaries, political affiliations, employee data, and more, in order to inform job seekers about ThermoGenesis Holdings. The employee data is based on information from people who have self-reported their past or current employments at ThermoGenesis Holdings. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by ThermoGenesis Holdings. The data presented on this page does not represent the view of ThermoGenesis Holdings and its employees or that of Zippia.
ThermoGenesis Holdings may also be known as or be related to CESCA THERAPEUTICS INC, CESCA THERAPEUTICS INC., Cesca Therapeutics, Cesca Therapeutics Inc, Cesca Therapeutics Inc., Cesca Therapeutics, Inc. and ThermoGenesis Holdings.